Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Dr. Reddy’s Laboratories Ltd.
Sort By
Newest First
Sign in
1 / 1
1 / 1
Partnership
Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan
Nice Insight
PR-M06-20-NI-043
Jul 02, 2020
Launch
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market
Dr. Reddy's Laboratories
PR-M08-19-NI-070
Aug 23, 2019
Biosimilar
Dr. Reddy's Laboratories Announces the Launch of Versavo® (bevacizumab biosimilar) in India
Dr. Reddy's Laboratories
PR-M08-19-NI-063
Aug 22, 2019
Announcement
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product
Aquestive Therapeutics
PR-M07-18-NI-053
Jul 17, 2018
FDA Approval
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Dr. Reddy's Laboratories
PR-M06-18-NI-063-4098
Jun 19, 2018
NDA
Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate
Dr. Reddy's Laboratories
PR-M04-18-NI-019
Apr 05, 2018
Licensing
Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology
Dr. Reddy's Laboratories
PR-M08-17-NI-005
Aug 22, 2017
